Outsourcing

Articles

Vectura has signed an agreement with Incannex Healthcare for the pre-clinical development of IHL-216A, an inhaled drug product for the treatment of traumatic brain injury.

Vectura Signs Agreement with Incannex to Advance TBI Treatment

Editor of Pharmaceutical Technology Europe

Thought and foresight into method development stages can ensure costly errors and delays are avoided later on.

Outlining the Key Steps to Method Development

Outsourcing method development offers multiple benefits to companies, including access to experience and expertise, streamlined costs, and development time efficiencies.

Developing a Method for Success through Partnerships

Xueqiang (Cliff) Yin is executive director, CMC Project Management, STA Pharmaceutical, a WuXi AppTec Company (WuXi STA).

An integrated CMC provider can help smaller companies to streamline development timelines and reduce project management complexity when compared with multi-provider models.

Expediting IND Submission

The rapid and efficient delivery of innovative treatments through the COVID-19 pandemic has demonstrated the value of collaborations within the bio/pharma industry.

Demonstrating the Value of Collaboration

Outsourcing partners can provide a multitude of advantages in the development of drug delivery solutions, including those designed for targeted patient populations.

Delivering a Wealth of Expertise

The right partner can help companies overcome key formulation challenges for biologic drugs.

Overcoming Biologic Drug Formulation Hurdles

More complex and challenging compounds require a more tailored approach to formulation strategies.

Unique Molecules Push Formulation Boundaries 

Bill Connell is a principal and supply chain practice leader at Tunnell Consulting.

Contract service providers offer vital services to bio/pharma companies of all sizes. Establishing an effective working relationship and managing operations are key to avoiding compliance issues.

Build CMO Relationships with Effective Management Practices

Catalent has unveiled plans to invest in a European center of excellence for clinical biologics formulation development and drug product fill/finish services at its facility in Limoges, France.

Contract Development Services